X

Safal Herbs Ltd. Stock Analysis

Small Cap
Evaluated by 43 users | BSE: 532034 | NSE: |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed 0.16%0.21%0.28%0.08%0.19%0.17%0.38%0.11%-0.15%-0.36%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 1.30.60.61.51.31.41.41.80.30.1
Y-o-Y Gr. Rt.--55.6%12.5%142.9%-18.3%15.2%-2.1%25.5%-80.8%-70.6%
Adjusted EPS (Rs.) 00000.050.030000
Y-o-Y Gr. Rt.-NANANANA-40%-100%NANANA
Book Value per Share (Rs.) 0.890.890.880.888.818.830.880.890.880.88
Adjusted Net Profit 00000.100000
Net Op. Cash Flow (Rs. Cr.) 000.2-0.3040-400
Debt to Cash Flow from Ops 0017.98-57.96-558.7400000
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Safal Herbs Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -24.5%-39.7%-58.6%-70.6%
Adjusted EPS NA-100%NANA
Book Value per Share -0.1-36.900
Share Price - -44.6% -39.5% -53.3%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) 0.160.210.340.160.510.310.380.11-0.15-0.36
Operating Profit Margin (%) 1.594.957.070.645.32.81.72-7.39-10.01-46.77
Net Profit Margin (%) 1.13.424.840.953.71.932.390.55-4.08-31.94
Debt to Equity 000.441.81.800000
Working Capital Days 05,9116,2534,4787,3754,3172,3131,8429,56832,317
Cash Conversion Cycle 01,5271,508673872514142-186539
Entity Percentage Holding
Promoters 9.62%
Institutions 3.00%
Non-Institutions 87.38%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Safal Herbs's performance infers:

Safal Herbs earnings have declined by -100%, whereas share price has depreciated -44.6% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

Data is not available for this company

No data to display
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback